The 17th "Nuclear Technology, Nuclear Applications, and Nuclear Economy" Forum, a premier annual event in China's nuclear science community, was held from June 12–15 in Shanghai's Zhangjiang Science City. Coinciding with the 70th anniversary of nuclear medicine in China, the forum was hosted by the Shanghai Nuclear Society and organized by several key institutions, including ShanghaiTech University and Shanghai Clinical Research and Trial Center.
The opening ceremony featured addresses from top officials of the Chinese Nuclear Society and prominent academicians. The event brought together leading academicians from across the country for high-level discussions covering nuclear medicine, nuclear physics, and advanced nuclear energy.
In-depth Parallel Sessions
On June 14, the nuclear medicine segment of the forum kicked off, structured around three thematic tracks that covered the entire spectrum from basic research to clinical innovation and industrial translation.
A session on molecular imaging delved into frontiers such as targeted drug delivery and AI applications, while a parallel track focused on the innovation and translation of radiopharmaceuticals, exploring the full chain from drug development to clinical integration. A third session on theranostics highlighted the expanding clinical applications of integrated diagnostic and therapeutic approaches.
Site Visit and Innovation Showcase
During the conference, attendees visited the nuclear medicine department at the Shanghai Clinical Research and Trial Center. The facility impressed experts with its advanced imaging equipment, including long-axis PET/CT and PET/MR systems, specialized theranostic treatment wards, and a comprehensive radiopharmaceutical production area featuring a cyclotron and quality control labs. The center's capabilities, such as being the first in China to perform whole-body multi-organ ¹⁵O-H₂O imaging, were particularly noted.
A Platform for Collaboration
A parallel innovation forum was also held on June 13, featuring additional focused discussions on precision cancer diagnosis and treatment. The event concluded with a call for continued collaboration to advance the field towards greater precision, intelligence, and industrial integration, providing a vital platform for professionals across the country to exchange ideas and build partnerships.
